新的EEHV疫苗在试验中安全保护大象,为对抗致命病毒提供希望。 A new EEHV vaccine safely protected elephants in trials, offering hope against a deadly virus.

抗大象内分泌病毒(EEHV)的新疫苗(EEHV)在早期试验中显示出安全和有效性。 这是一种致命的病毒,杀死年轻的亚洲大象。 A new vaccine against elephant endotheliotropic herpesvirus (EEHV), a deadly virus killing young Asian elephants, has shown safety and effectiveness in early trials. 在切斯特动物园对成年大象进行试验后,疫苗引发了强有力的免疫反应,没有副作用。 Tested on adult elephants at Chester Zoo, the vaccine triggered strong immune responses without side effects. 它由一个国际团队开发,使用一个有非感染性EEHV蛋白质的经证实的平台。 Developed by an international team, it uses a proven platform with non-infectious EEHV proteins. 这一突破为在动物园遭受重大损失之后保护被囚禁和野生的脆弱幼崽带来了希望。 The breakthrough offers hope for protecting vulnerable calves in captivity and the wild, following significant losses at zoos. 目前正在对年轻的大象和更广泛的人口进行进一步测试。 Further testing in young elephants and broader populations is underway.